Tandem Diabetes Care (TNDM) PT Raised to $97 at Oppenheimer

February 25, 2020 9:14 AM EST Send to a Friend

Oppenheimer analyst Steven Lichtman raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Tandem Diabetes Care (TNDM) PT Raised to $97 at Oppenheimer

Member Login

Free News Feed